| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,314 |
12,154 |
$1.11M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,432 |
8,610 |
$947K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,372 |
7,195 |
$335K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,711 |
2,683 |
$310K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,244 |
2,221 |
$252K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,739 |
1,668 |
$192K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,179 |
1,161 |
$140K |
| 90461 |
|
2,667 |
2,604 |
$92K |
| 92552 |
|
2,377 |
2,355 |
$74K |
| 97802 |
|
5,476 |
5,396 |
$45K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
486 |
477 |
$40K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,334 |
1,291 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,249 |
632 |
$18K |
| 99188 |
|
514 |
512 |
$14K |
| 81002 |
|
4,285 |
4,108 |
$12K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
302 |
296 |
$7K |
| 96160 |
|
2,786 |
2,744 |
$6K |
| 90716 |
|
568 |
563 |
$5K |
| 90707 |
|
619 |
615 |
$3K |
| 85018 |
|
1,252 |
1,236 |
$3K |
| 96127 |
|
1,001 |
953 |
$2K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
3,211 |
3,093 |
$2K |
| 90686 |
|
2,028 |
1,984 |
$2K |
| 90670 |
|
1,220 |
1,216 |
$1K |
| 0072A |
|
24 |
24 |
$960.00 |
| 0071A |
|
51 |
27 |
$960.00 |
| 0002A |
|
18 |
17 |
$680.00 |
| 90633 |
|
450 |
442 |
$555.79 |
| 90696 |
|
65 |
65 |
$507.16 |
| 99051 |
|
51 |
50 |
$499.38 |
| 87807 |
|
31 |
30 |
$466.35 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
321 |
296 |
$334.20 |
| 96161 |
|
72 |
64 |
$138.61 |
| 90700 |
|
159 |
157 |
$110.28 |
| 90656 |
|
87 |
86 |
$54.39 |
| 90648 |
|
473 |
472 |
$52.60 |
| 90651 |
|
116 |
115 |
$48.02 |
| 90674 |
|
39 |
39 |
$31.63 |
| 99177 |
|
3,164 |
2,590 |
$6.82 |
| 36416 |
|
2,002 |
1,739 |
$3.04 |
| 90698 |
|
108 |
106 |
$0.00 |
| 90680 |
|
669 |
664 |
$0.00 |
| 99000 |
|
90 |
75 |
$0.00 |
| 91307 |
|
54 |
27 |
$0.00 |
| 90619 |
|
15 |
15 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
12 |
$0.00 |
| 99173 |
|
47 |
46 |
$0.00 |
| 90671 |
|
104 |
103 |
$0.00 |
| 90734 |
|
13 |
12 |
$0.00 |
| 91300 |
|
14 |
13 |
$0.00 |
| 90715 |
|
24 |
24 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
16 |
15 |
$0.00 |